| # | Drug | Count |
|---|---|---|
| 0 | LEUPROLIDE ACETATE | 191 |
| 1 | DARBEPOETIN ALFA | 101 |
| 2 | CLOZAPINE | 85 |
| 3 | VENETOCLAX | 76 |
| 4 | DENOSUMAB | 68 |
| 5 | ACETAMINOPHEN | 62 |
| 6 | FUROSEMIDE | 54 |
| 7 | PANTOPRAZOLE | 43 |
| 8 | ASPIRIN | 41 |
| 9 | ASPIRIN 325 MG | 40 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACTEAMINOPHEN | 1 | 0.1111 |
| 1 | PURIFIED WATER | 1 | 0.0204 |
| 2 | CAPSICUM ANNUUM, FUCUS VESICULOSUS, BORAGE OFFICINALIS, LECITHIN, CALCAREA CARBONICA, FERRUM METALLICUM, KALI BICHROMICUM, KALI CARBONICA, PULSATILLA (PRATENSIS), SULPHUR | 1 | 0.0114 |
| 3 | TOLCAPONE | 3 | 0.0085 |
| 4 | TRASTUZUMAB-DKST | 2 | 0.0073 |
| 5 | ALUMINUM CHLORIDE | 1 | 0.0066 |
| 6 | USTEKINUMAB-STBA | 2 | 0.0054 |
| 7 | DIFELIKEFALIN | 2 | 0.0048 |
| 8 | FLUDEOXYGLUCOSE F-18 | 1 | 0.0035 |
| 9 | PRUCALOPRIDE SUCCINATE | 1 | 0.0029 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 105 |
| 1 | Erythropoiesis-stimulating Agent [EPC] | 101 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 87 |
| 3 | BCL-2 Inhibitor [EPC] | 76 |
| 4 | Corticosteroid [EPC] | 70 |
| 5 | RANK Ligand Inhibitor [EPC] | 68 |
| 6 | Benzodiazepine [EPC] | 61 |
| 7 | Loop Diuretic [EPC] | 61 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 51 |
| 9 | Kinase Inhibitor [EPC] | 48 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 20 | 0.0291 |
| 1 | Antileishmanial [EPC] | 1 | 0.0026 |
| 2 | Erythropoiesis-stimulating Agent [EPC] | 101 | 0.0019 |
| 3 | CD123 Interaction [EPC] | 1 | 0.0019 |
| 4 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 5 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 19 | 0.0014 |
| 6 | Catechol-O-Methyltransferase Inhibitor [EPC] | 7 | 0.0014 |
| 7 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 8 | BCL-2 Inhibitor [EPC] | 76 | 0.0012 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 7 | 0.0012 |